NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
LANGHORNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ:NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced a 12,000 square foot expansion of its CG Converting and Packaging facility in Granbury, Texas. The expansion will support the expected growth in product demand from its new strategic partnerships as well as continued growth of NEXGEL’s own branded products.
Related news for (NXGL)
- NEXGEL Reports First Quarter 2025 Financial Results
- NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results
- NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
- NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer
- NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially